Tuesday, January 9, 2024
November 05 - 07, 2022; Chicago, Illinois | Virtual
AHA 2022
Cognitive Behavioral Therapy App Lowers A1c in T2D
AHA 2022
CRT Boosts Heart Failure Survival in Extended Follow-Up
AHA 2022
Perceived Discrimination Tied to Worse Recovery After MI in Young
AHA 2022
Heart Disease Deaths Spiked During COVID After 10-Year Decline
KidneyWeek 2022
EMPA-Kidney Seals SGLT2 Inhibitors as 'Foundational' for CKD
AHA 2022
Patients Trying to Lose Weight Overestimate Their Diet Quality
AHA 2022
Leveraging Incidental CAC on Chest CT Boosts Statin Therapy
AHA 2022
Neurotoxin to Avert Postoperative AF: Patient Selection Clues in NOVA
AHA 2022
Patient App Aids Decisions on Anticoagulants: ENHANCE-AF
AHA 2022
Exercise Rx in Breast Cancer Care Gets a Boost From BREXIT
AHA 2022
Renal Denervation Trial for Hypertension Is a Near Miss
AHA 2022
Be Aware, Mindfulness Training Can Lower Systolic BP: MB-BP
AHA 2022
Tirzepatide Cuts BP During Obesity Treatment
AHA 2022
Statins Boost Glycemia Slightly, but CVD Benefits Prevail
AHA 2022
IRONMAN Galvanizes Case for IV Iron Repletion in Heart Failure
AHA 2022
Baxdrostat Slashes BP in Resistant Hypertension: BrigHTN
AHA 2022
BRIGHT-4: Is Bivalirudin Poised for a Comeback in STEMI PCI?
AHA 2022
First-Line AF Ablation Cuts Risk of Progression vs Drug Therapy
AHA 2022
No Benefit of Rivaroxaban in COVID Outpatients: PREVENT-HD
AHA 2022
Rapidly Optimize HF Meds After Hospital Discharge: STRONG-HF
AHA 2022
If a Saphenous Graft Is Available, Treat CLTI Surgically
AHA 2022
EHR-based Thromboembolism Risk Tools Boosts Prophylaxis
AHA 2022
Four-Drug Combo Gets BP Down in One Step: QUARTET-USA
AHA 2022
Precision CAD Testing Shows 70% Cut in Composite Risk at 1 Year
AHA 2022
Steroids Fail to Deliver Clear Benefits in Infant Heart Surgery
AHA 2022
Dietary Supplements Hyped as LDL-Lowering Are a Bust: SPORT
AHA 2022
In Refractory VF, DSED or VC Defibrillation Both Beat Standard Tx
AHA 2022
Olpasiran Provides Large Sustained Cut in Lp(a): OCEAN(a)-DOSE
AHA 2022
ISCHEMIA-EXTEND: Conservative CAD Management Holds Up
AHA 2022
New Trial Suggests CV Benefit With EPA: RESPECT-EPA
AHA 2022
Acute Heart Failure Risk Assessment Improves Outcomes
AHA 2022
In CABG, Radial Artery Works Best for Second Key Graft
AHA 2022
Chinese Herbal Medicine May Offer Benefits in STEMI: CTS-AMI
AHA 2022
Avoid Routine Early ECMO in Severe Cardiogenic Shock: ECMO-CS
AHA 2022
CRISPR Gene Editing Takes Next Step in TTR Amyloidosis
AHA 2022
No Survival Gain for Torsemide vs Furosemide in HF: TRANSFORM-HF
AHA 2022
Triglyceride Lowering Fails to Show CV Benefit in Large Fibrate Trial
AHA 2022
Diuretic Agents Equal to Prevent CV Events in Hypertension: DCP
AHA 2022
Heart Transplant Outcomes Similar With COVID-19–Positive Donors
AHA 2022
Puzzling, Unique ECG From Pig-to-Human Transplanted Heart
AHA 2022
Edoxaban Safe, Effective in Kids With Heart Disease: ENNOBLE-ATE
AHA 2022
Marital Stress Tied to Worse Outcome in Young MI Patients
AHA 2022
Uptake of High-Sensitivity Troponin Assays Lags in US Hospitals
AHA 2022
AHA 2022 to Recapture In-Person Vibe but Preserve Global Reach
© WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Diabetes and Heart Disease Highlights From AHA 2022
Is Finding and Fixing Iron Deficiency in HF Beneficial?
HerStory: The AHA Presidential Address That Could Change Medicine
Does Lp(a) Play a Causal Role in ASCVD?
Did ISCHEMIA Change the Path to Cath in Stable CAD?
STRONG-HF Strategy for Intense ADHF Discharge Care Explained
Role of Ablation Type and Risk Factors in Paroxysmal AF
Meds and Community Over Mindfulness for Most Hypertension
Heart Supplements Flunk Lipid Lowering Test: SPORT Interview
STRONG HF: More Beats Less After Discharge for Heart Failure
Is Iron Replacement in Heart Failure Worth the Trouble?
HCTZ vs Chlorthalidone -- A Win for Practicing Doctors and Science
Mandrola's Top 5 Picks From AHA 2022 Previewed
